Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Aeon
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Overvaluation Will Exacerbate Legacy Retail Struggles Despite Digital Upside
Key Takeaways Reliance on legacy retail and slow adaptation to digital trends leave Aeon vulnerable to margin pressure, falling foot traffic, and relentless online competition. Demographic headwinds, emerging market risks, and costly regulatory adaptation threaten long-term profitability and stable bottom-line growth.
View narrative
JP¥1.65k
FV
235.9% overvalued
intrinsic discount
1.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Geberit
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Europe's Demographic Stagnation And Decarbonization Costs Will Hinder Prospects
Key Takeaways Demographic stagnation and housing trends in core European markets constrain demand, while cost pressures and regulatory demands threaten to erode profitability and margins. Market saturation, limited pricing power, and lower per-unit spending on premium products combine with rising costs to suppress sales growth and compress net margins.
View narrative
CHF 408.00
FV
53.8% overvalued
intrinsic discount
3.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Kaspi.kz
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Cybersecurity Threats And Kazakhstan Exposure Will Stifle Expansion
Key Takeaways Heightened regulatory, geopolitical, and competitive pressures could constrain Kaspi.kz's growth opportunities, compress margins, and increase operational risks. Heavy dependence on Kazakhstan and costly expansion efforts may expose the company to volatile earnings and limit its ability to offset challenges through diversification.
View narrative
US$85.53
FV
9.5% overvalued
intrinsic discount
11.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Astellas Pharma
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Patent Expirations And Price Reforms Will Erode Future Margins
Key Takeaways Loss of exclusivity for major drugs and persistent R&D challenges threaten future revenue stability and hinder the replacement of expiring blockbusters. Pricing pressures, regulatory risks, and supply chain complexities increase margin volatility and operational uncertainty across key global markets.
View narrative
JP¥1.30k
FV
30.8% overvalued
intrinsic discount
-6.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
REA Group
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Aging Australian Market And Tighter Data Laws Will Erode Margins
Key Takeaways Long-term demographics and market saturation threaten REA Group's growth as housing transactions and user engagement decline. Regulatory, competitive, and cost pressures risk shrinking margins, undermining AI investments, and limiting future earnings potential.
View narrative
AU$178.60
FV
46.3% overvalued
intrinsic discount
2.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Capitec Bank Holdings
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Digital Disruption And Regulatory Pressures Will Undermine Future Prospects
Key Takeaways Digital disruption and intense competition from fintechs and established players threaten Capitec's traditional revenue streams and force costly technology investments. Economic headwinds and regulatory pressures heighten credit risk, compress margins, and limit innovation, undermining profitability and earnings quality.
View narrative
R2.91k
FV
24.5% overvalued
intrinsic discount
24.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Straumann Holding
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Rising Regulation And Cost Pressures Will Curb Premium Dental Demand
Key Takeaways Erosion of demand for premium dental products threatens revenue growth, aggravated by cost pressures, tougher regulations, and intensifying global competition. Disruptive business models and commoditization risk undermining Straumann's traditional market dominance, shrinking the addressable market and compressing operating margins.
View narrative
CHF 85.00
FV
11.6% overvalued
intrinsic discount
6.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
WuXi AppTec
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Rising US-China Tensions And Overcapacity Will Curtail Prospects
Key Takeaways Geopolitical tensions and regulatory scrutiny threaten WuXi AppTec's client base, cost structure, and market positioning as global firms localize supply chains. Aggressive expansion and capital commitments increase exposure to demand slowdowns, risking underutilized assets and declining profitability as industry funding stagnates.
View narrative
CN¥89.70
FV
0.6% overvalued
intrinsic discount
10.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Sonova Holding
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Low-Cost Rivals And Digital Shifts Will Erode Premium Pricing
Key Takeaways The rise of low-cost competitors, new technologies, and commoditization threatens Sonova's pricing power, market share, and overall growth prospects. Regulatory pressures, rising costs, and declining clinic profitability are undermining margins and limiting the company's ability to sustain earnings.
View narrative
CHF 189.00
FV
20.3% overvalued
intrinsic discount
4.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies